MAPT and Alzheimer disease: AADvac1 is a therapeutic tau vaccine candidate that has shown successful reduction of neurofilament light chain (NfL) in plasma and CSF in AD patients by recognizing a 12-amino acid sequence (KDNIKHVPGGGS) in tau MTBR.